Search company, investor...

Dybly

dybly.com

Founded Year

2006

Stage

Other Investors | Alive

About Dybly

Atherosclerosis, Circomed, Biotech, Stroke, Intermittent Claudication, ischemia, heart attack, arteriosclerosis, schaufensterkrankheit, leg, infarctus, cardiovascular, leg pain, pain, cramp, leg cramp, arteriosclerosis, peripheral arterial disease, PAD, peripheral vascular disease, PVD, tingling, ApoA1, Apo-A1, Apo-AI, ApoAI, Atherosklerose, arteriosklerose, investment, round A, blockbuster, lipid, lipid management, HDL, LDL, Triglycerides, claudicatio, claudication, ischemic event, prevention, cure, sclerosis, sklerose, PAOD, PVD, circulation, bad circulation, pharmaceutical, product development, early-stage biotech, circomed, dybly, barbara staehelin, henri zinsli, herman kempen, resverlogix, esperion

Headquarters Location

Birsigstrasse 46

4054,

Switzerland

Missing: Dybly's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Dybly's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Dybly Patents

Dybly has filed 1 patent.

The 3 most popular patent topics include:

  • Experimental cancer drugs
  • Proteins
  • Transcription factors
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/6/2020

2/2/2021

Transcription factors, Experimental cancer drugs, Proteins, Monoclonal antibodies, Protein domains

Grant

Application Date

3/6/2020

Grant Date

2/2/2021

Title

Related Topics

Transcription factors, Experimental cancer drugs, Proteins, Monoclonal antibodies, Protein domains

Status

Grant

Dybly Frequently Asked Questions (FAQ)

  • When was Dybly founded?

    Dybly was founded in 2006.

  • What is Dybly's latest funding round?

    Dybly's latest funding round is Other Investors.

  • Who are the investors of Dybly?

    Investors of Dybly include Erfindungs Verwertung.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.